Q SQUARED SOLUTIONS CHINA LIMITED

Active Reading

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
Q

Q SQUARED SOLUTIONS CHINA LIMITED

Research and experimental development on biotechnology

Founded 19 Jun 2015 Active Reading, United Kingdom 0 employees website.com
Research and experimental development on biotechnology

Previous Company Names

CLINICAL LAB SERVICES CHINA LIMITED 19 Jun 2015 — 1 Jul 2015
Accounts Submitted 10 Jul 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 23 Jun 2025 Next due 3 Jul 2026 21 days remaining
Net assets £14M £0 2024 year on year
Total assets £14M £0 2024 year on year
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

3 Forbury Place 23 Forbury Road Reading RG1 3JH United Kingdom

Full company profile for Q SQUARED SOLUTIONS CHINA LIMITED (09648736), an active company based in Reading, United Kingdom. Incorporated 19 Jun 2015. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type dormant
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

N/A

Net Assets

£13.96M

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Elaine LoweyDirectorBritishUnited Kingdom4726 Jul 2024Active
Kevin John TurlandDirectorBritishUnited Kingdom578 Oct 2015Active

Shareholders

Shareholders (11)

Q Squared Solutions Holdings Limited
100.0%
1,100,000
Ims Software Services Limited
0.0%
0

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

IQVIA RDS HOLDINGS united kingdom
IQVIA LTD. united kingdom
IQVIA BIOTECH LTD. united kingdom
Q SQUARED SOLUTIONS CHINA LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Jul 2025AccountsAnnual accounts made up to 31 Dec 2024
23 Jun 2025Confirmation StatementConfirmation statement made on 19 Jun 2025 with updates
3 Nov 2024ResolutionResolutions
30 Oct 2024CapitalCapital Alter Shares Subdivision
29 Jul 2024OfficersTermination of Tony Brown as director on 26 Jul 2024
10 Jul 2025 Accounts

Annual accounts made up to 31 Dec 2024

23 Jun 2025 Confirmation Statement

Confirmation statement made on 19 Jun 2025 with updates

3 Nov 2024 Resolution

Resolutions

30 Oct 2024 Capital

Capital Alter Shares Subdivision

29 Jul 2024 Officers

Termination of Tony Brown as director on 26 Jul 2024

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2024

11 months ago on 10 Jul 2025

Confirmation statement made on 19 Jun 2025 with updates

11 months ago on 23 Jun 2025

Resolutions

1 years ago on 3 Nov 2024

Capital Alter Shares Subdivision

1 years ago on 30 Oct 2024

Termination of Tony Brown as director on 26 Jul 2024

1 years ago on 29 Jul 2024